Abnormal correlation between serum leptin levels and body mass index may predict metabolic dysfunction irrespective of the psychopharmacological treatment

International Clinical Psychopharmacology

Volumn 26, Issue 3, 2011, Pages 169-172

  Marquina, David ^a   Peña, Rocio ^a   Fernández, Erika ^b   Baptista, Trino ^a  

^a Universidad De Los Andes Facultad de Medicina   (Venezuela)

^b UNIVERSIDAD DEL ZULIA   (Venezuela)

Author keywords

atypical antipsychotics; genotype; leptin; metabolic syndrome; obesity; receptors

Indexed keywords

CLOZAPINE; INSULIN; LEPTIN; NEUROLEPTIC AGENT; OLANZAPINE; TRIACYLGLYCEROL;

AGE; ARTICLE; BODY MASS; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HORMONE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PREDICTION; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; SEX; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ANTIPSYCHOTIC AGENTS; BLOOD GLUCOSE; BODY COMPOSITION; BODY MASS INDEX; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; LEPTIN; MALE; METABOLIC SYNDROME X; OBESITY; PSYCHOTIC DISORDERS; TRIGLYCERIDES; WAIST CIRCUMFERENCE;

EID: 79954822323     PISSN: 02681315     EISSN: 14735857     Source Type: Journal    
DOI: 10.1097/YIC.0b013e328342ce47     Document Type: Article

References (14)

1. Alberti KG, Zimmet P, Shaw J (2006). Metabolic syndrome: a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 23:469-480.
2. Baptista T, Dávila A, ElFakih Y, Uzcátegui E, Rangel N, Olivares Y, et al. (2007). Similar frequency of abnormal correlation between serum leptin levels and body mass index before and after olanzapine treatment in schizophrenia. Int Clin Psychopharmacol 22:205-211. (Pubitemid 46801943)
3. Ellingrod V, Bishop R, Moline J, Lin YC, Del Miller D (2007). Leptin and leptin receptor gene polymorphisms and increases in body mass index (BMI) from olanzapine treatment in persons with schizophrenia. Psychopharmacol Bull 40:57-62.
4. Ferná ndez E, Carrizo E, Fernández V, Connell L, Sandia I, Prieto D, et al. (2010). Polymorphisms of the LEP- and LEPR genes, metabolic profile after prolonged clozapine administration and response to the antidiabetic metformin. Schiz Res. 121; 213-217.
5. Gregoor JG, Van der Weide J, Mulder H, Cohen D, Van Megen HJ, Egberts AC (2009). Polymorphisms of the LEP- and LEPR gene and obesity in patients using antipsychotic medication. J Clin Psychopharmacol 29:21-25.
6. Haupt DW, Luber A, Maeda J, Melson AK, Schweiger JA, Newcomer JW (2005). Plasma leptin and adiposity during antipsychotic treatment of schizophrenia. Neuropsychopharmacol 30:184-191. (Pubitemid 40024412)
7. Kang SG, Lee HJ, Park YM, Choi JE, Han C, Kim YK, et al. (2008). Possible association between the -2548A/G polymorphism of the leptin gene and olanzapine-induced weight gain. Prog Neuropsychopharmacol Biol Psychiatry 32:160-163.
8. Kelesidis T, Kelesidis I, Chou S, Mantzoros CS (2010). The role of leptin in human physiology: emerging clinical applications. Ann Intern Med 152:93-100.
9. Melkersson KI, Hulting A, Brismar KE (2000). Elevated levels of insulin, leptin and blood lipids in olanzapine-treated patients with schizophrenia or related psychoses. J Clin Psychiatry 61:742-749.
10. Peña R, Marquina D, Serrano A, ElFakih Y, Carrizo E, Fernandez V, et al. (2008). Frequency of abnormal correlation between leptin and the body mass index during first and second generation antipsychotic drug treatment. Schiz Res 106:315-319.
11. Ryu SH, Jang WS, Cho EY, Kim SK, Lee DS, Hong KS (2006). Association study of -2548A/G polymorphism of leptin gene with antipsychotics-induced weight gain. Korean J Psychopharmacol 17:423-438.
12. Templeman LA, Reynolds GP, Arranz B, San L (2005). Polymorphisms of the 5-HT2Creceptor and leptin genes are associated with antipsychotic drug-induced weight gain in Caucasian subjects with a first-episode psychosis. Pharmacogenet Genomics 15:195-200. (Pubitemid 40569890)
13. Zhang ZJ, Yao ZJ, Mou XD, Chen JF, Zhuk RX, Liu W, et al. (2003). Association of -2548G/A functional polymorphism in the promoter region of leptin gene with antipsychotic agent-induced weight gain. Zhonghua Yi Xue Za Zhi 83:2119-2123.
14. Zhang XY, Tan YL, Zhou DF, Haile CN, Cao LY, Xu Q, et al. (2007). Association of clozapine-induced weight gain with a polymorphism in the leptin promoter region in patients with chronic schizophrenia in a Chinese population. J Clin Psychopharmacol 27:246-251. (Pubitemid 46763305)